It is a healthcare public limited company based in Hyderabad, Telangana, India, established in 2004.
2004 | Hyderabad, Telangana, India | ActiveRevag Biosciences Limited, a active public limited company, was established on 07 July 2004 in Hyderabad, Telangana, India. Engaging in preventive health services within the hospital and medical care sector, it holds CIN: U24239TG2004PLC043602. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Laxminarayana Rau Praharaju (Director), Rajyalakshmi Praharaju (Director), Anurag Athreya Praharaju (Director). Past directors included Rajyalakshmi Praharaju, Venkatasubbarao Potluri, Anurag Athreya Praharaju. It holds ₹0.55 M open charges and ₹1.70 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No 35E1 Phase 5 Ida Cherlapally, Hyderabad, Telangana, 500051.
U24239TG2004PLC043602
043602
07 July 2004
₹0.50 M
₹0.50 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Revag Biosciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Laxminarayana Rau Praharaju | Director | 07 Jul 2004 | Current |
| Rajyalakshmi Praharaju | Director | 21 Mar 2018 | Current |
| Anurag Athreya Praharaju | Director | 21 Mar 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 26 Mar 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Whole-Time Director | 26 Mar 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Revag Biosciences Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 49.42% increase in profit. The company's net worth dipped by a decrease of 3.32%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Revag Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹550,000.00
₹17,035,891.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Sep 2020 | State Bank Of India | ₹1.65 Cr | Satisfied |
| 20 Mar 2015 | State Bank Of Hyderabad | ₹0.55 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Revag Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Revag Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Revag Biosciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 20 Mar 2015 via Charge ID 10567567 with State Bank Of Hyderabad was fully satisfied on 28 Jul 2025. was documented.
The activity A charge registered on 01 Sep 2020 via Charge ID 100386942 with State Bank Of India was fully satisfied on 25 Jun 2025. was completed.
Progress on Revag Biosciences Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Revag Biosciences Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
A charge with State Bank Of India amounted to Rs. 16.49 M with Charge ID 100386942 was registered on 01 Sep 2020. was recorded as a recent event.
Progress on Rajyalakshmi Praharaju was appointed as a Director was appointed as a Director on 21 Mar 2018 & has been associated with this company since 7 years 8 months . was documented.
The CIN of Revag Biosciences Limited is U24239TG2004PLC043602.
Revag Biosciences Limited is headquartered at Plot No 35E1 Phase 5 Ida Cherlapally, Hyderabad, Telangana, 500051.
Revag Biosciences Limited was incorporated on 07 July 2004.
The current directors of Revag Biosciences Limited are
The primary industry of Revag Biosciences Limited is Hospital And Medical Care.
Revag Biosciences Limited is unlisted.
The authorized capital of Revag Biosciences Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Revag Biosciences Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX